My NCBISign In

Display Settings:

Format

Send to:

Choose Destination

    Exp Transl Stroke Med. 2010 Jan 5;2:1.

    Interleukin-18 does not influence infarct volume or functional outcome in the early stage after transient focal brain ischemia in mice.

    Braeuninger S, Kleinschnitz C, Stoll G.

    Department of Neurology, Julius-Maximilians-Universitaet Wuerzburg, Josef-Schneider-Strasse 11, D-97080 Wuerzburg, Germany.

    Abstract

    Interleukin-18 (IL-18) is a proinflammatory cytokine of the interleukin-1 family which is upregulated after cerebral ischemia. The functional role of IL-18 in cerebral ischemia is unknown. In the present study, we compared infarct size in IL-18 knock-out and wild-type mice 24 hours and 48 hours after 1-hour transient middle cerebral artery occlusion (tMCAO). Moreover, the functional outcome was evaluated in a modified Bederson score, foot fault test and grip test. There were no significant differences in infarct size or functional outcome tests between wild-type and IL-18 knock-out mice. These data indicate that the early inflammatory response to cerebral ischemia does not involve IL-18, in contrast to other interleukin-1 family members such as interleukin-1.

    PMID: 20150990 [PubMed]PMCID: PMC2820471Free PMC Article

    Supplemental Content

    Click here to read Click here to read

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...
    Write to the Help Desk